Martine de Boer is a Researcher at Erasmus MC's Department of Cardiology, specializing in cardiovascular molecular mechanisms and cardiac imaging. Her research examines the intersection of DNA repair pathways and cardiac function, particularly in heart failure contexts. Her investigations span: Molecular mechanisms of DNA damage/repair in cardiomyocytes Cardiac imaging techniques including micro-CT and echocardiography Apoptosis pathways in heart failure progression Exercise-induced cardiac adaptation mechanisms Age-related vascular dysfunction Rodent models of cardiac disease De Boer's publications demonstrate consistent focus on translational cardiology, with recent work (2023-2024) emphasizing molecular imaging and DNA repair pathways in cardiac failure models. Her collaborative research involves multi-institutional teams across Europe.
Eduardo Mascareno is an Assistant Professor in the Department of Cell Biology at SUNY Downstate Health Sciences University, specializing in molecular mechanisms linking obesity, cardiovascular disease, and cellular signaling pathways. His research focuses on leptin's role in cardiovascular regulation, Jak/Stat signaling, and the local tissue renin-angiotensin system (RAS) during cardiac hypertrophy. Institution: SUNY Downstate Health Sciences University Department: Cell Biology Academic Rank: Assistant Professor Email: emascareno@downstate.edu Key research themes include: Leptin receptor signaling in cardiovascular tissues Jak/Stat pathway activation in cardiac RAS regulation Hexim1's role in obesity-glucose metabolism links Myeloid inflammation states in renal cancer recurrence Transcriptional regulation during heart development Recent publications examine: 2022: Myeloid inflammatory states in renal cancer recurrence 2021: Mental health impacts of pandemic on respiratory patients 2020: Leptin's differential regulation of lipid metabolism 2017: Hexim1's protective roles in infectious and metabolic diseases 2012: Cross-regulation of cancer signaling networks 2009: Cardiac gene expression during hypertrophy
Dr. Thomas Netticadan serves as an Adjunct Professor in the Department of Physiology and Pathophysiology at the University of Manitoba while holding multiple leadership roles including Team Leader at the Canadian Centre for Agri-food Research in Health and Medicine, Research Scientist at Agriculture and Agri-Food Canada, and Principal Investigator of the Heart Failure Research Laboratory at the Morden Research and Development Centre. His research centers on cardiac hypertrophy mechanisms in heart failure development, utilizing experimental rat models of pressure overload (aortic banding), volume overload (aortocaval shunt), and combined overload (coronary artery ligation). A key focus involves investigating nutraceuticals like resveratrol as antihypertrophic agents, with demonstrated success in preventing pressure overload-induced hypertrophy through nitric oxide synthase induction. Dr. Netticadan leads the Heart Failure Research Laboratory where his team explores cellular pathways of pathological cardiac remodeling and identifies novel therapeutic targets for heart failure treatment, bridging agri-food research with cardiovascular medicine.
Paul Herijgers is a full professor at the Faculty of Medicine , KU Leuven , affiliated with the Department of Cardiovascular Sciences and Cardiac Surgery unit. He leads the Division of Cardiac Research and serves as Managing Director of UZ Leuven. Research Interests His work focuses on: Cardiac surgical techniques including minimally invasive approaches Infectious endocarditis management and outcomes Anatomical skill training for surgical proficiency Academic Leadership He holds key roles in institutional governance: Division Head of Cardiac Research Member of iSi Health Institute Participant in KU Leuven R&D and Medical Faculty councils
Konstantin Hennis is a Researcher at the Department of Cardiovascular Physiology and Pathophysiology, Biomedical Center Munich, Ludwig Maximilians University Munich. His work focuses on ion channel biophysics, cardiac electrophysiology, and lysosomal signaling mechanisms. Major research themes include HCN channel function, inflammasome activation, and microRNA regulation in cardiac pathophysiology. Recent publications highlight his contributions to understanding pacemaker channel hysteresis, OCaR protein-mediated calcium release, and E-selectin signaling in neutrophil-mediated cardiac inflammation. His studies employ advanced electrophysiological, imaging, and telemetric techniques. Collaborations with the Wahl-Schott Group and international teams have produced insights into sinoatrial node dynamics and novel nonfiring cell modes. Current projects bridge basic science and translational applications in cardiac rhythm disorders.
Dr. Alexander S. Clanachan is a Professor in the Department of Pharmacology at the University of Alberta, Faculty of Medicine & Dentistry, specializing in pharmacotherapy for myocardial ischemia-reperfusion injury. His work targets novel drug mechanisms to improve cardiac recovery in stressed hearts (e.g., diabetic, aged, or delayed-reperfusion scenarios). His educational background includes: BSc Hons Pharmacology, University of Glasgow, 1972 PhD Pharmacology/Anesthesia, University of Glasgow, 1976 Research Interests: Dr. Clanachan investigates: Recovery of left ventricular mechanical/metabolic function post-ischemia Na + /Ca 2+ homeostasis regulation Infarct size limitation pathways Cardioprotection via adenosine receptors and late I Na inhibition His lab employs model systems to quantify drug effects on cardiac efficiency, energy substrate metabolism, calcium overload, and signaling (GSK-3β, AMPK, p38MAPK). Analysis of his 15 recent publications (2011-2016) reveals consistent focus on metabolic-ionic crosstalk in reperfusion injury, particularly in diabetic hearts and anesthetic interactions. Key trends include adenosine-mediated glycogen regulation, late I Na inhibition for calcium control, and ROS-dependent cardioprotection mechanisms. Scientific Awards: No awards were mentioned in the source material. Advising and Grants: Dr. Clanachan mentors Research Associate Dr. Phing How Lou and teaches Pharmacology courses (PMCOL415, PMCOL337, PMCOL300*, PMCOL515*). Grant details were unspecified, but his collaborative projects span anesthesiology, diabetes, and cardiac metabolism. Laboratory: His lab (Medical Sciences Building, Room 9-43) conducts isolated heart perfusion studies, metabolic profiling, and molecular analysis of cardioprotective pathways.
John M Seubert serves as an Adjunct Associate Professor in the Department of Pharmacology at the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences. His research program investigates cytochrome P450-derived metabolites of arachidonic acid, particularly epoxyeicosatrienoic acids (EETs), in cardiac protection and mitochondrial regulation. His educational background includes: BSc Biology (Toxicology) and Psychology Minor, Simon Fraser University (1992) MSc Biology - Aquatic Toxicology, Simon Fraser University (1997) PhD Pharmacology and Toxicology, University of Western Ontario (2002) Dr. Seubert's research focuses on two primary areas: (1) The cardioprotective mechanisms of EETs in ischemia-reperfusion injury, utilizing transgenic mouse models with elevated EET levels and cardiomyocyte experiments; (2) EET-mediated regulation of mitochondrial dynamics and energetics in cellular survival pathways. His laboratory employs techniques including murine cardiac injury models, mitochondrial function assays, and lipid mediator analysis. Analysis of his recent publications reveals strong emphasis on translational cardioprotection, with recurring themes in EET pharmacology, mitochondrial integrity during stress, and therapeutic targeting of soluble epoxide hydrolase. His work bridges molecular cardiology with pharmacological intervention strategies. Professional activities include teaching PHARM367 and PHARM566 courses, with laboratory operations based in the Katz Group Centre (Room 2-020M). Current research directions involve sEH inhibition strategies and mitochondrial protection pathways.
Heike Bruch is a Professor of Leadership and Director of the Institute for Leadership and Human Resource Management (IFPM-HSG) at the University of St. Gallen. Her research focuses on leadership, organizational energy, healthy high performance, new forms of work, employer attractiveness, and demographic management. She leads studies like the 'Trend Barometer: People Management' series, analyzing future HR trends, technological disruptions, and cultural transformation. Her work emphasizes integrating AI and agile methodologies while fostering modern workplace cultures. Her key publications include studies on leadership transitions, ambidextrous leadership, and the impact of customer contact on organizational energy. She collaborates with institutions like PwC and the German Society for Human Resource Management. Current projects address digital transformation in HR, workforce strategy, and overcoming cultural gaps in organizational change. She advises on strategic HR challenges, including talent acquisition, employee experience, and leadership development. Her team includes researchers like Julia Lara Forjan and administrative staff like Sabrina Jann. The IFPM-HSG is part of the School of Business, Economics, Law, Social Sciences, International Relations, and Computer Science at the University of St. Gallen.
Craig Goergen is a Professor of Biomedical Engineering and Courtesy Professor of Mechanical Engineering at Purdue University's Weldon School of Biomedical Engineering. His research focuses on cardiovascular biomechanics, medical imaging technologies, and wearable health monitoring systems. Key areas include strain analysis in cardiomyopathy, 4D ultrasound applications, and translational medical device development. He leads interdisciplinary projects combining engineering and clinical insights, with a strong emphasis on advancing diagnostics for muscular dystrophy and heart failure. Research interests span biomedical engineering, cardiac mechanics, and wearable sensor technologies. Recent work explores novel 3D-printed microrobots for drug delivery, personalized digital biomarkers using wearable data, and computational models for blood flow dynamics. His team develops innovative imaging techniques like 4D strain tracking and photoacoustic tomography to study cardiovascular pathologies. Publications highlight advancements in cardiac strain mapping, murine models of heart disease, and medical device prototyping. He collaborates with clinical partners to translate engineering solutions into clinical practice, particularly in areas like hypertrophic cardiomyopathy and Duchenne muscular dystrophy-associated cardiomyopathy.
William Minozzi is Professor of Political Science and Director of Research at the Institute for Democratic Engagement and Accountability (IDEA) at Ohio State University. His research examines legislative politics, deliberative democracy, political communication, and experimental methodology. Minozzi's work includes experimental studies of political communication, historical analysis of Congressional behavior, and field experiments on public deliberation. Key research areas include campaign messaging, legislative responsiveness to party pressure, voter decision-making biases, and the impacts of deliberative forums on political attitudes. His publications employ diverse methodologies including game theory, field experiments, machine learning, and historical analysis. Recent work investigates how campaign spending influences Congressional control, how communication formats shape information exchange, and how deliberation affects civic attitudes. Research Leadership: As IDEA Director of Research, Minozzi oversees studies on democratic engagement, including large-scale field experiments with Members of Congress. He co-leads the Connecting Classrooms to Congress initiative funded by the Institute of Education Sciences. Minozzi teaches courses on causal inference, legislative politics, and political methodology at graduate and undergraduate levels.
Sarah Kuzmiak-Glancy Dr. Sarah Kuzmiak-Glancy is an Assistant Professor in the Department of Kinesiology at the University of Maryland's School of Public Health. Her research focuses on mitochondrial energetics in skeletal and cardiac muscles, particularly how energy production is matched to demand during exercise and disease. She holds a BS in Exercise Science (Rutgers, 2008), PhD in Biology (Arizona State, 2012), and postdoctoral training in Biomedical Engineering (George Washington University, 2012–2016) and Cardiology (National Heart, Lung, and Blood Institute, NIH, 2016). Research Interests Heart and skeletal muscle metabolism Mitochondrial function and dysfunction Exercise physiology and disease adaptations Age-related mitochondrial changes Her work investigates mechanisms underlying mitochondrial coordination with energy demand, including studies on calcium handling, phosphate regulation, and stress responses in heart failure and genetic diseases like sickle cell anemia. Recent publications highlight novel insights into mitochondrial reorganization during hypoxia, calcium overload, and aging. Awards & Grants No specific awards are listed, though her research is supported by grants focusing on mitochondrial dynamics and cardiovascular health. She collaborates across disciplines to advance understanding of energy metabolism in disease contexts. Lab & Team Her lab integrates biochemical, physiological, and animal model approaches to study mitochondrial energetics. Collaborations include NIH researchers and biomedical engineers to develop translational insights into cardiac and muscle disorders.
Lixin Ma is an Associate Professor in the Department of Radiology at the University of Missouri School of Medicine. His research develops receptor-targeted nanoparticles for cancer imaging and therapy, quantitative MRI techniques, and multimodality contrast agents. His work spans structural drug design and NMR spectroscopy applications in biomedical imaging. Research Expertise: Receptor-avid tumor targeting nanoparticles Ultrafast magnetic resonance imaging Multimodality contrast agents Structural-based anticancer drug development
Jose Ramirez-Marquez is an Associate Professor and Division Director of Enterprise Science and Engineering at Stevens Institute of Technology's Charles V. Schaefer, Jr. School of Engineering and Science. He holds a PhD in Industrial and Systems Engineering from Rutgers University (2004), along with advanced degrees in Statistics and Actuarial Science. His research focuses on three key areas: Urban Informatics (analyzing city systems and infrastructure resilience), Data Visualization for Decision Making (using visual techniques to address complex societal issues), and AI/ML Techniques (applied to urban and architectural challenges). Dr. Ramirez-Marquez has over 25 years of research experience, with over 100 publications in technical journals and industry reports. Notable honors include the 2010 Davis Memorial Award for Research Excellence. He leads projects funded by agencies like NSF, the Department of Defense, and the Volvo Research Foundation, totaling over $2M in grants since 2020. Current initiatives include AI tools for defense acquisition reform, NLP-based talent management systems, and resilience strategies for smart cities. He teaches courses in reliability engineering, data visualization, and socio-technical systems. Institutional roles include membership in the Faculty Senate, NSF-Aspire diversity committee, and doctoral review committees. His work bridges computational methods with societal challenges, emphasizing equity in urban systems and disaster response.
Ivana Kuo, PhD, is an Associate Professor at the Department of Cell & Molecular Physiology within the Stritch School of Medicine at Loyola University Chicago. Her research focuses on intracellular calcium signaling, cardio-renal crosstalk, and genetic kidney disease, particularly investigating the role of polycystin-2 in disease mechanisms. The Kuo laboratory employs electrophysiology, live-cell imaging, and in-vivo/ex-vivo methodologies to study calcium-modulating pathways in conditions such as polycystic kidney disease and hypertension. The lab is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research interests include understanding how disruptions in calcium signaling lead to cardiac and renal pathologies, with a focus on polycystin proteins and their roles in organ-level communication. Recent work highlights the importance of polycystin-2 in natriuretic peptide signaling, hypertension regulation, and cardiac dysfunction in autosomal dominant polycystic kidney disease (ADPKD). Publications span molecular mechanisms of calcium channels, organ-level interactions, and translational applications of genetic models. Key findings include the role of polycystin-2 in modulating cardiac calcium cycling and its implications for heart failure. The lab also explores novel imaging techniques and therapeutic targets for renal and cardiovascular diseases. Funding: NIDDK grant actively supports ongoing research. The Kuo Lab collaborates on projects involving multi-organ signaling, with particular emphasis on translational studies linking basic research to clinical outcomes.
Peter Darke is Professor of Marketing and Director of the PhD Program at York University's Schulich School of Business. His research examines emotional, motivational, and cognitive aspects of consumer judgment and decision-making, particularly investigating whether judgment biases might have adaptive benefits. This work has significant implications for marketing practices in advertising, sales, behavioral pricing, promotions, and word-of-mouth behavior. His primary research interests focus on consumer psychology in marketing contexts, including behavioral biases in information processing, ethical decision-making, and persuasion mechanisms. Darke's work bridges theoretical behavioral science and practical marketing applications, exploring how cognitive shortcuts and emotional responses influence consumer choices. Analysis of Darke's 15 most recent publications reveals consistent themes in consumer psychology research: the psychology of trust/deception in advertising, cognitive biases in judgment, cross-cultural decision-making patterns, and persuasion mechanisms in digital environments. His work demonstrates methodological diversity including experimental designs, behavioral modeling, and cross-cultural comparative studies.
